Brain Metastases In ErbB2-Positive Breast Cancer

PHASE2

Phase

TERMINATED

Status

Enrollment

INDUSTRY

Sponsor class

Stopped Lapatinib-topotecan arm enrollment closed early per protocol amendment 2. Then enrollment into remaining arm terminated due to operational issues.

Conditions

Neoplasms, Breast

Interventions

DRUG: capecitabine
DRUG: topotecan
DRUG: lapatinib

Sponsor

GlaxoSmithKline